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Abstract 
In August 2014, a puffer fish poisoning incidence resulting in one fatality was reported in New 
Caledonia. Although tetrodotoxin (TTX) intoxication was established from the patients’ signs 
and symptoms, the determination of TTX in the patient’s urine, serum or plasma is essential to 
confirm the clinical diagnosis. To provide a simple cost-effective rapid screening tool for clinical 
analysis, a maleimide-based enzyme-linked immunosorbent assay (mELISA) adapted for the 
determination of TTX contents in human body fluids was assessed. The mELISA was applied to 
the analysis of urine samples from two patients and a response for the presence of TTX and/or 
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structurally similar analogues was detected in all samples. The analysis by LC-MS/MS 
confirmed the presence of TTX but also TTX analogues (4-epiTTX, 4,9-anhydroTTX and 5,6,11-
trideoxyTTX) in the urine. A change in the multi-toxin profile in the urine based on time 
following consumption was observed. LC-MS/MS analysis of serum and plasma samples also 
revealed the presence of TTX (32.9 ng/mL) and 5,6,11-trideoxyTTX (374.6 ng/mL) in the post-
mortem plasma. The results provide for the first time the TTX multi-toxin profile of human 
samples from a puffer fish intoxication and clearly demonstrate the implication of TTX as the 
causative agent of the reported intoxication case. 
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1. INTRODUCTION 
Tetrodotoxin (TTX) is one of the most potent low-molecular-weight marine neurotoxin, well-
known for its distribution in puffer fish, but also present in many other organisms, including 
amphibians, echinoderms, cephalopods and bivalve molluscs (Noguchi et al., 2008; Turner et 
al. 2017). It is believed to be primarily produced by certain marine endosymbiotic bacteria and 
to accumulate through the food webs and enter into other organisms, eventually reaching 
humans (Pratheepa and Vasconcelos, 2013). TTX and TTX analogues selectively bind to site one 
of voltage-gated sodium channels, blocking the influx of sodium ions into the nerve cells and 
affecting neuromuscular transmission, causing progressive paralysis and even death due to a 
failure of the respiratory system (Lee and Ruben, 2008). 
Puffer fish food poisoning cases have been reported worldwide. A poisoning incidence 
reported by the Territorial Hospital of New Caledonia in August 2014 resulting from the 
ingestion of an Arothron nigropunctatus puffer fish (Maillaud et al., 2015) is addressed in this 
work to demonstrate the implication of TTX in this intoxication. At around 6 pm on the 27th of 
August, four men aged 33, 34, 37 and 38 years old, with no known medical history, consumed 
a boiled fish that the oldest man had captured whilst fishing. The older fisherman ate most of 
the liver and the gonads in their totality. One of the other men consumed, the flesh in great 
quantity and, the other man consumed, a small portion of the liver. The fourth and youngest 
man only ingested a small part of the flesh. Rapidly, the first three consumers presented with 
gastrointestinal signs such as nausea, vomiting and diffuse abdominal pain, together with 
neurological signs such as peribuccal, facial and extremal paraesthesia and ataxia-like 
sensations. The three men lay down and fell asleep. On the morning of the 28th of August, the 
fisherman was found deceased in his bed and the other two men showed regressed digestive 
signs and appearance of tetraparesis. The fourth consumer returned home with no signs of 
intoxication. The two men that presented with neurological signs were hospitalised, one 
patient in the intensive care unit (Pt#1) and the other one (Pt#2) in the short stay 
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hospitalization unit of the Territorial Hospital of New Caledonia. The neurological symptoms 
with associating tetraparesis, tetraparesthesis, ataxia and deep sensitivity disturbance 
dissipated after 48 hours and disappeared in a few days. 
Although the causative agent of the food poisoning was established from the patients’ 
symptoms and the identification of the species responsible through the photos of the fish 
provided by the medical team to one of the patients, the puffer fish could not be analysed for 
the identification of the toxin involved in this intoxication case. Thus, the detection of TTXs in 
clinical samples of the poisoned patients can be essential to confirm TTX intoxication. As TTXs 
are very polar compounds, the ingested toxins are mainly eliminated in urine. Previous studies 
have indicated that TTXs only remain in blood for a matter of hours (less than 24 h), but they 
can be found in urine even on day 4 after ingestion (O’Leary et al., 2004). 
Chromatography-based methods have been to date the most widely used techniques for the 
determination of TTXs in the urine and blood of patients from poisoning incidents. However, 
determining TTX intoxication from body fluids faces certain challenges. First, unlike in food, the 
amount of toxin in the urine and blood of a patient who has been intoxicated is typically low; 
therefore, a sensitive method is required. Secondly, because TTXs are very polar compounds, 
there will be low retention on conventional reverse-phase columns; thus, the use of another 
type of analytical column or modification of the mobile phase composition is needed. Third, 
endogenous metabolites of the biological samples may lead to matrix effects. Ion suppression 
is a big challenge in mass spectrometry (MS) analysis, requiring efficient clean-up procedures 
before sample analysis (Leung et al., 2011). 
Enzyme-linked immunosorbent assays (ELISAs) are rapid, sensitive, cost-efficient and easy-to-
use methods of analysis that do not require sophisticated instrumentation and highly trained 
personnel. The use of ELISAs as alternative or complementary to conventional methods for the 
determination of TTXs in biological samples can provide expedient solutions for rapid and 
reliable diagnosis in food poisoning incidences, and favours their implementation at hospitals 
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where patients are treated. A maleimide-based ELISA (mELISA) for the detection of TTXs in 
mussels and oysters was recently developed at IRTA (Reverté et al., 2017). The TTX was 
immobilised on self-assembled cysteamine in a stable, ordered and optimally-oriented way 
that provided a long-term stability for storage of the modified microtiter plates, allowing the 
assay to be performed in less than 2 hours with the use of these pre-coated plates. To the best 
of our knowledge, only one work has used an immunoassay for the analysis of human body 
fluids for TTX monitoring, but no details are provided on the method or its performance (Islam 
et al., 2011). Here, the application of the mELISA to the screening of TTXs in clinical samples 
was assessed and fully characterised by the analysis of blank and TTX-spiked samples. 
Moreover, urine samples from the two intoxicated patients were analysed and the multi-toxin 
profile (TTX and TTX analogues) in urine, serum and plasma samples was evaluated by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) analysis. The results obtained by 
both techniques were compared, demonstrating the applicability of the immunoassay and the 
complementarity of the techniques based on different recognition principles. 
 
2. MATERIALS AND METHODS 
2.1. Reagents and materials 
Pure TTX standard was purchased from Tocris Bioscience (Bristol, UK) and standard solutions 
were prepared at 1 mg/mL in 10 mM acetic acid (AA). The anti-TTX monoclonal antibody 
(mAb) TX-7F was produced as described in Kawatsu et al. (1997). Pierce maleimide-activated 
plates were obtained from Thermo Fisher Scientific (Madrid, Spain). Cysteamine 
hydrochloride, formaldehyde solution, anti-mouse IgG (whole molecule)-horseradish 
peroxidase antibody produced in rabbit (IgG-HRP), bovine serum albumin (BSA), 
ethylenediaminetetraacetic acid (EDTA), 4-morpholineethanesulfonic acid (MES) hydrate, 
potassium phosphate dibasic, potassium phosphate monobasic and 3,3’,5,5’-
tetramethylbenzidine (TMB) liquid substrate, ammonium hydroxide solution (NH4OH, 25%), 
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ammonium acetate and amorphous graphitized polymer carbon Supelco ENVI-Carb 
250 mg/3 mL cartridges were supplied by Sigma-Aldrich (Tres Cantos, Spain). HPLC-grade 
acetonitrile (ACN), glacial acetic acid (AA) and methanol (MeOH) were obtained from Chem-lab 
(Zedelgem, Belgium). Ultrapure Milli-Q water (18.2 MΩ/cm2) was used for the preparation of 
solutions (Millipore Iberica Ltd., Madrid, Spain). 
 
2.2. Human samples 
Urine, serum and plasma samples were collected and stored at -20 °C until their analysis (Table 
1). Urine and serum samples from patient 1 (Pt#1) were collected the 28th and 29th of August 
2014, coinciding with ~17 h and ~45 h after the ingestion of the boiled puffer fish; urine and 
serum samples from patient 2 (Pt#2) were taken only the second day of hospitalisation, 
approximately 42 h after the ingestion of the fish. Three plasma samples were collected from 
Pt#1: the first one was collected at the moment of hospitalisation, ~17 h after the puffer fish 
consumption; two additional samples were collected ~38 and ~43 h after the ingestion; only 
one plasma sample was collected from Pt#2, ~23 h after the fish consumption. A post-mortem 
plasma sample was collected from the fisherman, ~17 h after the puffer fish ingestion. 
Table 1. Human body fluid samples collected from the two hospitalised patients and the 
deceased fisherman.  
 Date 
Time  
(hours  after 
ingestion) 
Samples 
Pt#1 
28/08/14 17 h Urine, serum and heparinized plasma 
29/08/14 38 h Heparinized plasma 
29/08/14 43 h Heparinized plasma 
29/08/14 45h Urine and serum 
Pt#2 
28/08/14 23 h Heparinized plasma 
29/08/14 42 h Urine and serum 
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Fisherman 28/08/14 17 h Post-mortem plasma (with fluoride) 
 
The creatinine concentration in urine samples was determined by Echevarne Laboratory 
(Barcelona, Spain) using Jaffe's reaction. 
 
2.3. Colorimetric maleimide-based enzyme-linked immunosorbent assay (mELISA) 
Urine samples were analysed by mELISA, using the protocol previously developed by our group 
for the determination of TTX in shellfish (Reverté et al., 2018). Briefly, 100  L of 1 mM 
cysteamine in binding buffer (0.1 M potassium phosphate, 10 mM EDTA, pH 7.2) was added to 
the maleimide plates and incubated for 3 h, followed by the direct immobilization of TTX (2 
 µg/mL) with formaldehyde (3.4%) in the same buffer overnight. A competitive assay was then 
performed by incubating 50  L of free TTX/sample dilution and 50 µL of 1:1,600 anti-TTX 
monoclonal antibody (mAb) dilution in 1% BSA-phosphate buffer for 30 min. A blocking step 
was then performed with 200 µL of 1% BSA-phosphate buffer for 30 min and, finally, 100 µL of 
IgG- HRP at 1:1,000 dilution in 1% BSA-phosphate buffer was incubated for 30 min. The 
colorimetric response was measured at 620 nm after 10 min of TMB liquid substrate 
incubation. 
 
2.4. Solid-phase extraction (SPE) clean-up 
Solid-phase extraction (SPE) clean-up was used before LC-MS/MS analysis, adapting the 
protocol described by Boundy et al. (2015) for shellfish samples. In this work, the addition of 
NH4OH to the crude extract is avoided. Briefly, graphitized polymer carbon ENVI-carb 
cartridges were conditioned with 3 mL of ACN/H2O/AA (20:80:1, v:v:v), followed by 3 mL of 
H2O/NH4OH (1000:1, v:v). Then, 400 µL of sample was loaded onto the conditioned cartridges 
and washed with 700 µL of deionized H2O. Finally, the retained TTXs were eluted with 2 mL of 
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ACN/H2O/AA (20:80:1, v:v:v). The eluent was diluted by transferring 100 µL to an insert and 
adding 100 µL of ACN. Sample vials could be stored at -20 °C until analysis. 
 
2.5. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis 
Urine, serum and plasma samples were analysed by LC-MS/MS, using the protocol previously 
developed by our group for the analysis of puffer fish (Rambla-Alegre et al., 2017). Briefly, a 
TSQ Quantum system (Thermo Fisher Scientific, Bremen, Germany) and a HILIC XBridge Amide 
column were used; a binary gradient elution was programmed with H2O (mobile phase A) and 
ACN/H2O (mobile phase B), both containing ammonium acetate and adjusted to pH 5.8 with 
acetic acid. Extracts were analysed by electrospray ionisation (ESI) operating in positive mode, 
[M+H]+; multiple reaction monitoring (MRM) transitions were monitored for the following TTX 
analogues (precursor ion > product ion): 320.1 > 302.1 / 162.2 for TTX and 4-epiTTX, 302.1 > 
256.1 / 162.2 for 4,9-anhydroTTX, 304.1 > 286.1 / 162.2 for 5-deoxyTTX and 11-deoxyTTX, 
288.1 > 270.1 / 224.0 for 5,11-dideoxyTTX and 6,11-dideoxyTTX, 272.1 > 254.1 / 162.2 for 
5,6,11-trideoxyTTX, 290.1 > 272.1 / 162.2 for 11-norTTX-6(S)-ol and 11-norTTX-6(R)-ol; 
identification was supported by the toxin retention time and MRM ion ratios. ESI parameters 
and voltages were optimised to: spray voltage of 3.5 kV, capillary temperature of 300 °C, 
sheath gas flow rate of 40 (arbitrary units) and auxiliary gas flow rate of 10 (arbitrary units), 
capillary voltage of 30.0 V, tube lens voltage of 130 V and skimmer voltage of 28 V. Data was 
processed with Xcalibur 2.0.7 SP1 software (ThermoFisher Scientific, Bremen, Germany).  
Quantification was calculated through an external calibration using TTX standard as a 
reference. Six level calibration curves between 1- 250 ng/mL showed good intra-batch 
performance and linear adjustment (r2) ≥ 0.9990. According to the recoveries and dilution 
factor of the samples, the working ranges of the method in urine, plasma and serum were 12-
2,909 ng/mL, 25-6,361 ng/mL and 22-5,447 ng/mL, respectively. 
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3. RESULTS AND DISCUSSION 
3.1. Detection of TTX equivalent content in human samples by mELISA 
3.1.1. Matrix effects and TTX recovery 
When performing an immunoassay, the functionality of the antibodies can be strongly affected 
by the presence of matrix compounds other than the target analyte, thus, the effect of each 
type of matrix on the assay should be evaluated prior to the analysis of naturally contaminated 
samples. To test urine matrix effects, pure and diluted blank and spiked (5 ng/mL TTX) urine 
samples were analysed. The mAb binding percentages obtained ranged between 95 and 104% 
for pure blank urine samples and all dilutions tested, indicating the lack of interference from 
urine matrix in the recognition of the immobilised TTX by the mAb. In contrast, urine matrix 
effects on the recognition of free TTX by the mAb were observed in the analysis of TTX-spiked 
urine samples, obtaining toxin recoveries of 27±4% in pure urine samples. Toxin recoveries 
increased with sample dilutions, reaching 101±2% recovery at ¼-diluted samples. Thus, it was 
clearly demonstrated that ¼ dilution of urine in buffer is an effective way to overcome matrix 
effects, avoiding sample pre-treatment. Considering ¼ urine dilution and the limit of detection 
(LOD) obtained in the standard calibration curve in buffer (IC10=0.9 ng/mL), an effective LOD 
(eLOD) of 3.6 ng TTX/mL urine was calculated, with a working range (IC20–IC80) between 6.1 
and 184.0 ng TTX/mL urine. However, urine is a fluid with a large variation in matrix 
components and concentrations, differing both among people and within the same person 
depending on the status of dehydration of the patient. Thus, when the analysis is not 
compromised by analyte concentrations below the LOD, additional sample dilutions are 
encouraged to validate that the matrix effect has been completely removed and TTX equiv. 
content is not being underestimated. 
In regards to the serum and plasma samples, the preliminary studies revealed high non-
specific absorption values from the secondary antibody in blank serum and plasma samples –
from pure samples to ⅛ sample dilutions in binding buffer–. Due to the high interference of the 
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matrix components in serum and plasma, the analysis of these clinical samples by mELISA was 
not fulfilled. Since mELISA is proposed as a rapid screening tool, the clean-up of serum and 
plasma samples to reduce the matrix effects was not approached. Determination of TTX in 
urine by mELISA is an appropriate strategy for clinical laboratory diagnosis due to the low 
matrix effects but also the long duration of TTX in urine compared with plasma and serum. 
 
3.1.2. Quantification of TTX equivalent content in urine samples 
Urine samples were analysed by mELISA to determine the TTX equiv. contents (Table 2). TTX 
equiv. were detected in all urine samples. To eliminate the effect of dehydration and variations 
in urinary output of the patients, urine creatinine adjustment of the TTX concentrations was 
made (Yu et al., 2010; Fong et al., 2011) expressing the concentration of TTX equiv. in relation 
to creatinine concentrations (ng TTX equiv./µmol creatinine). It was found that urine 
creatinine-adjusted TTX (UC-TTX) concentrations agree well with the degree of poisoning, as 
observed from clinical symptoms, and with the expected TTX excretion rates. In Pt#1, the urine 
sample collected ~17 h after fish ingestion presented the highest UC-TTX concentration. The 
UC-TTX content decreased in the urine sampled from the same patient ~45 h after fish 
ingestion. Urine sample from Pt#2, collected ~42 h after fish ingestion, showed the lowest UC-
TTX levels. TTX equiv. contents found in urine are consistent with previous TTX intoxication 
episodes reported (Yu et al., 2010). However, in many cases the results are difficult to compare 
due to differences in the urine collection time and differences in the hydration state of 
patients and no adjustment with creatinine levels. 
 
3.2. Detection of TTXs in human samples by LC-MS/MS analysis 
3.2.1. TTX recovery 
Urine, serum and plasma matrix effects were studied by the analysis of blank and TTX-spiked 
matrices. After SPE clean-up of the samples, toxin recoveries of 43%, 23% and 20% were 
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obtained for urine, serum and plasma samples, respectively. The low recovery values achieved 
in the analysis of the clinical samples can be attributed to toxin loss during SPE clean-up and/or 
ion suppression. Nevertheless, these toxin recovery values are taken as correction factors (CFs) 
and will be applied in the quantifications obtained in the subsequent analysis of naturally 
contaminated samples extracted and treated under these conditions. 
After applying the corresponding CFs, LODs of 5.9, 10.9 and 12.7 ng TTX/mL and limits of 
quantification (LOQs) of 11.6, 21.8 and 25.4 ng TTX/mL were calculated for urine, serum and 
plasma samples, respectively. 
 
 
3.2.2. Identification and quantification of TTXs 
TTX content in urine, serum and plasma samples was evaluated by LC-MS/MS. As expected 
from the previous results obtained by mELISA, TTX was detected in all urine samples. Figure 1 
shows the chromatograms obtained after the analysis of the urine sample of Pt#2, as an 
example. The analysis revealed a multi-toxin profile in all urine samples, with the presence of 
TTX but also 4- epiTTX, 4,9-anhydroTTX and 5,6,11-trideoxyTTX analogues (Table 2, Figure 2). It 
is interesting to mention that whereas 5,6,11-trideoxyTTX was the major analogue found in 
urine from Pt#1 collected ~17 h after the puffer fish ingestion, TTX was the major compound 
found in urine from the same patient collected ~45 h after the fish ingestion. Urine sample 
from Pt#2, collected ~42 h after the fish ingestion, also presented TTX as the major compound. 
Concentrations of TTX and TTX analogues obtained could suggest the metabolism of 5,6,11-
trideoxyTTX to TTX and its equivalent analogues 4-epiTTX and 4,9-anhydroTTX, a pathway 
already predicted by Yotsu-Yamashita et al. (2013). After adjusting TTX and TTX analogues 
values to creatinine concentration to correct the effect of dehydration and variations in urinary 
output, as performed in the quantifications by mELISA (section 3.1.2), a decrease of TTX and all 
the analogue concentrations was observed with time (hours after fish consumption). 
12 
 
Consequently, the TTX metabolic pathway cannot be concluded from these results since 
differences in the metabolic profile could also be explained by the different stability of TTX 
analogues.  
 
Figure 1.  
Figure 2.  
 
To obtain an estimation of the total TTX content of a sample in terms of toxicity (expressed in 
TTX equiv.), the application of the toxicity equivalency factors (TEFs) of each analogue to the 
individual quantifications provided by LC-MS/MS is necessary. TEFs express the toxicity of each 
individual analogue in relation to TTX toxicity used as a reference. Thus, TEFs for 4-epiTTX 
(TEF4- epiTTX=0.156), 4,9-anhydroTTX (TEF4,9-anhydroTTX=0.019) and 5,6,11-trideoxyTTX (TEF5,6,11-
 trideoxyTTX=0.011) previously established in the literature (Nakamura and Yasumoto 1985; Yotsu-
Yamashita et al. 1995) were applied to each TTX analogue concentration in urine samples, 
obtaining TTX equiv. concentrations, which were afterwards adjusted according to creatinine 
concentrations. A correspondence between the adjusted values and the clinical symptoms of 
the patients was again observed.  
Regarding serum and plasma samples from the hospitalised patients, neither TTX nor TTX 
analogues were detected above the LODs, which indicates the rapid elimination of TTX into 
urine. In contrast, TTX and 5,6,11-trideoxyTTX were detected in the post-mortem plasma 
sample from the fisherman at concentrations of 32.9 ng/mL and 374.6 ng/mL, respectively 
(Figure 3). Although 5,6,11-trideoxyTTX was clearly the major compound detected in the 
plasma, its low toxicity compared with TTX points out TTX to be the main causative agent of 
this fatal case. It is important to take into consideration that blood TTX concentrations greater 
than 9 ng/mL have been suggested to be potentially lethal (Islam et al., 2011). The detection of 
TTX in the post-mortem plasma at this high concentration clearly reflects the high amount of 
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TTX ingested by the fisherman, probably due to the consumption of liver and gonads, the most 
toxic parts of puffer fish species (Noguchi et al., 2008). 
 
Figure 3.  
 
3.3. Comparison between TTX quantifications provided by mELISA and by LC-MS/MS analysis 
The application of cross-reactivity factors (CRFs) of TTX analogues to the individual contents 
determined by LC-MS/MS to obtain the total TTX content of a sample in terms of 
immunochemical recognition (expressed in TTX equiv.), is crucial when comparing results 
between immunochemical and physicochemical approaches. CRFs depend on the affinity of 
the antibody for the different analogues, but also on the immunological approach and the 
manner in which antibodies/antigens are immobilised (Reverté et al., 2015; Leonardo et al., 
2017). CRFs for 4,9- anhydroTTX and 5,6,11-trideoxyTTX analogues were previously established 
by mELISA, being 10-4 and 10-6, respectively. Unfortunately, the CRF for 4-epiTTX could not be 
established due to the lack of standard. The total TTX equiv. content by LC-MS/MS was 
calculated by adding up the contents of TTX and TTX analogues after applying the 
corresponding CRFs to each analogue (Table 2). The low CRFs of 4,9-anhydroTTX and 5,6,11-
trideoxyTTX certainly makes the contribution of these analogues to the total sum to be very 
low. Since CRF for 4-epiTTX was not available, the CRF values of 0 and 1 were assumed for this 
analogue to provide a content range that should include the real values (this affects to samples 
from Pt#1, as 4-epiTTX was not quantified in sample from Pt#2). After creatinine adjustment, 
appropriate correlations between the C-TTX quantifications provided by mELISA and LC-
MS/MS analysis were obtained, regardless of whether 4-epiTTX CRF was considered to be 0 
(  = 1.288   – 17.2, R2 = 0.995) or 1 (  = 0.717   – 3.8, R2 = 0.993). Due to the small amount of 
4-epiTTX in relation to the total TTX content of the sample, no significant differences were 
observed either when the CRF applied was 0 (t=0.405, p=0.706) or 1 (t=0.813, p=0.462). 
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Nevertheless, p-values obtained suggest that the real value should be closer to 0, the affinity 
of the antibody to recognise 4-epiTTX in the mELISA probably being very low in comparison 
with TTX. 
The interaction of toxins with antibodies is based on a structural recognition that is not 
necessary related to the toxicity. Ideally, an immunoassay should be able not only to recognise 
all toxic analogues that contribute to the intoxication case, but also to provide a quantification 
equivalent to the total toxicity. Thus, quantifications provided by mELISA were also compared 
with total TTX equiv. concentrations calculated after LC-MS/MS analysis. Good correlations 
were obtained (  = 1.050   – 11.5, R2 = 0.990) with results showing no significant differences 
(t=0.547, p=0.614). The lower affinity of the mAb towards less toxic TTX analogues in 
comparison with TTX makes the mELISA an ideal tool for preliminary screening of the toxicity 
of urine samples. Since only three urine samples were available in this study, additional 
samples should be analysed to fully validate this method. Nevertheless, the obtained results 
clearly demonstrate the applicability of the mELISA to both fast screening and quantification of 
TTX in urine samples in a simple and reliable way. 
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Table 2. TTX and creatinine concentrations in urine samples of two patients with TTX poisoning and comparison between TTX quantifications provided by 
LC-MS/MS analysis and mELISA. 
  
TTX 
(ng/mL) 
Creatinine 
(µmol/L) 
UC-TTX 
(ng/µmol creatinine) 
  LC-MS/MS mELISA LC-MS/MS mELISA 
 
Hours 
after 
ingestion 
TTX 
4-
epiTTX 
4,9-
anhydroTTX 
5,6,11-
trideoxy
TTX 
TTX equiv. 
(applying 
TEFs) 
TTX equiv. 
(applying 
CRFs) 
TTX 
equiv.  
TTX equiv. 
(applying 
TEFs) 
TTX equiv.  
(applying 
CRFs) 
TTX 
equiv.  
Pt#1 17 217.4 101.2 108.3 1008.2 246.3 217.4−318.6 211.1 3,890 63.3 55.9−81.9 54.3 
Pt#1 45 683.9 149.0 184.7 171.6 712.6 683.9−833.9 561.4 20,774 34.3 32.9−40.1 27.0 
Pt#2 42 65.4 n.d.* 23.0 31.8 66.2 65.4 32.0 2,829 23.4 23.1 11.3 
*n.d.: not detected 
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4. CONCLUSIONS 
The implication of TTX as the responsible agent of the reported intoxication case in New 
Caledonia following consumption of puffer fish has been proven. 
The applicability of the mELISA to the analysis of urine samples has been demonstrated, 
confirming the presence of TTX equiv. in all urine samples from the hospitalised patients. The 
results were in good correlation with LC-MS/MS analysis, that revealed a multi-toxin profile, 
with the presence of TTX and three TTX analogues (4-epiTTX, 4,9-anhydroTTX and 5,6,11-
trideoxyTTX). No TTXs were detected in plasma and serum of these patients by LC-MS/MS 
analysis, but TTX and 5,6,11-trideoxyTTX were detected in the post-mortem plasma of the 
fisherman at a lethal concentration of 37.0 ng/mL, after applying the TEFs. 
The results obtained herein show the mELISA as a powerful tool for the fast screening of TTXs 
in urine samples, surpassing some of the challenges associated with LC-MS/MS analysis (e.g. 
lack of retention on conventional reverse-phase columns or significant ion suppression due to 
endogenous substances in urine). The analysis of urine samples by mELISA is a reliable, simple 
and cost-effective strategy to estimate the degree of TTX poisoning in humans. The 
complementary analysis by LC-MS/MS performed in parallel confirms the causative 
intoxication agent and provide a full characterisation of the multi-toxin profile of the sample. 
This work constitutes the first report that describes the multi-toxin profile in urine and post-
mortem plasma samples after puffer fish consumption, and complements the previous 
information on TTX present in human samples. 
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 Figure 1. Total ion chromatogram (TIC) and MRM chromatogram of transitions monitored 
obtained following the analysis of TTX and its analogues in urine from Pt#2 by LC-MS/MS. 
Arrows indicate TTX and TTX analogues peaks identified. 
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Figure 2. Graphical representation of the multi-toxin profile of the urine samples. 
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Figure 3. TIC and MRM chromatogram of transitions monitored obtained following the analysis 
of TTX and its analogues in post-mortem plasma from the fisherman by LC-MS/MS. Arrows 
indicate TTX and TTX analogues peaks identified. 
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